Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decline in Short Interest

Posted by Brenda Bartman on Jul 28th, 2026

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 9,653 shares, a decline of 58.6% from the June 30th total of 23,325 shares. Currently, 0.5% of the shares of the stock are short sold. Based on an average trading volume of 133,939 shares, the days-to-cover ratio is currently 0.1 days.

Arcadia Biosciences Trading Up 0.9%

NASDAQ RKDA traded up $0.01 during trading hours on Tuesday, reaching $0.64. 14,402 shares of the company’s stock were exchanged, compared to its average volume of 1,368,741. The firm has a fifty day moving average of $0.80 and a 200-day moving average of $1.37. Arcadia Biosciences has a one year low of $0.59 and a one year high of $6.71. The stock has a market cap of $1.40 million, a PE ratio of -0.11 and a beta of 0.54.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). The business had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

View Our Latest Analysis on Arcadia Biosciences

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.